Ticker Details
Fulgent Genetics, Inc. Fulgent Genetics Inc is a technology company offering genetic testing to provide physicians with clinically actionable diagnostic information used to improve the overall quality of patient care.
IPO Date:	September 29, 2016
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$716.55M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.89 | 2.84%
Avg Daily Range (30 D):	$0.28 | 1.07%
Avg Daily Range (90 D):	$0.33 | 1.28%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.19M

Trade Size
Avg Trade Size (Sh.):	62
Avg Trade Size (Sh.) (30 D):	34
Avg Trade Size (Sh.) (90 D):	37

Institutional Trades
Total Institutional Trades:	1,867
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$.84M
Avg Institutional Trade (90 D):	$1.03M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.87M
Avg Closing Trade (30 D):	$.85M
Avg Closing Trade (90 D):	$1.06M
Avg Closing Volume:	44.18K

News

Jan 30, 2026 @ 9:57 AM Esoteric Testing Research Report 2026 - Global $41... Source: Researchandmarkets.Com

Aug 1, 2025 @ 8:26 PM Why Fulgent Genetics Stock Was Crushing It on Frid... Source: Eric Volkman

Jul 15, 2025 @ 11:41 PM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C.

Jul 1, 2025 @ 1:00 AM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C.

Jun 23, 2025 @ 4:53 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS
Diluted EPS
Revenue	$315.55M	$84.07M	$81.8M
Gross Profit	$130.14M	$35.51M	$34.44M
Net Income / Loss	$-44.17M	$-6.83M	$-19.26M
Operating Income / Loss	$-70.99M	$-15.35M	$-19.71M
Cost of Revenue	$185.41M	$48.56M	$47.37M
Net Cash Flow	$59.6M	$29.76M	$20.6M
PE Ratio